-
Syndax Announces Participation at Two Upcoming Investor Conferences
-
Syndax Announces Participation at the Citi 18th Annual BioPharma Conference
-
Syndax Announces Participation at Upcoming Investor Conferences
-
Syndax Announces Participation at Citi's Biopharma Virtual Co-Panel Day
-
Syndax Announces Participation at Three Upcoming Investor Conferences
-
UPDATE: Citi Starts Syndax Pharmaceuticals (SNDX) at Buy
-
Syndax Announces Closing of Public Offering and Exercise in Full of the Underwriters' Option to Purchase Additional Shares
-
Syndax Pharmaceuticals (SNDX) Prices 5.43M Share Public Offering of Common Stock at $23/sh
-
Syndax Announces Pricing of Public Offering of Common Stock
-
Syndax Pharmaceuticals (SNDX) Announces Proposed Public Offering of Common Stock
-
Syndax Announces Proposed Public Offering of Common Stock
-
Syndax Announces Participation at Three Upcoming Investor Conferences
-
Citi Upgrades Syndax Pharmaceuticals (SNDX) to Buy
-
UPDATE: Citi Downgrades Syndax Pharmaceuticals (SNDX) to Neutral
-
Syndax Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
-
Syndax Pharmaceuticals (SNDX) Prices 5.56M Common Stock Offering at $18/sh
-
Syndax Announces Pricing of Public Offering of Common Stock
-
Syndax Pharmaceuticals (SNDX) Announces Proposed Public Offering of Common Stock
-
Syndax Announces Proposed Public Offering of Common Stock
-
Syndax Announces Participation at Four Upcoming Investor Conferences
-
Syndax Pharmaceuticals (SNDX) PT Lowered to $12 at Citi
-
Syndax Pharmaceuticals (SNDX) Appoints Jennifer Jarrett and William Meury to Board Succeeding Luke Evnin Ph.D. and Henry Chen
-
Syndax Announces Changes to its Board of Directors
-
Syndax Announces Participation at Three Upcoming Investor Conferences
-
Syndax Pharmaceuticals (SNDX) PT Lowered to $15 at Citi
-
Pre-Open Movers 03/06: (AMDA) (CLBS) (GNCA) Higher; (GLYC) (FRPT) (ASNA) Lower (more...)
-
Syndax Pharmaceuticals Announces Participation at Three Upcoming Investor Conferences
-
Syndax Pharmaceuticals (SNDX) PT Lowered to $20 at Citi; Reiterates Buy
-
Syndax Pharmaceuticals Reports Second Quarter 2017 Financial Results and Provides Clinical and Business Update
-
Syndax Pharmaceuticals (SNDX) Prices 3.75M Share Offering at $13.25/Sh
-
Syndax Prices Public Offering of Common Stock
-
Syndax Pharmaceuticals (SNDX) Announces $50M Offering of Common Stock
-
Syndax Announces Proposed Public Offering of Common Stock
-
Syndax Pharmaceuticals (SNDX): Early Ph2 Data Encouraging - Citi
-
Syndax Pharmaceuticals Reports Third Quarter 2016 Financial Results and Provides Business Update
-
Syndax Pharmaceuticals Announces Participation at Four Upcoming Investor Conferences
-
Syndax Pharmaceuticals Reports Second Quarter 2016 Financial Results and Provides Business Update
-
Syndax Pharmaceuticals (SNDX) IPO Opens Flat
-
Syndax Announces Pricing of Initial Public Offering

